Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
Lithium carbonate is a small-molecule mood stabilizer approved for bipolar disorder, acute bipolar depression, and major depressive disorder. Its mechanism of action remains incompletely understood, though it is hypothesized to work through multiple neurobiological pathways. It is completely absorbed orally with peak concentrations within 0.25–3 hours and is not metabolized, being excreted unchanged in urine with an 18–36 hour half-life.
As an approaching loss-of-exclusivity generic with high competitive pressure (60/100), lithium carbonate teams are transitioning from growth to defense and cost optimization.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects
Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects
Worked on LITHIUM CARBONATE at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on lithium carbonate offers exposure to a foundational psychiatry therapy with established clinical relevance and long-term market presence, but limited growth upside due to LOE approaching status and high generic competition. Career value lies in managed markets negotiation, cost-of-therapy optimization, and clinical evidence synthesis rather than innovation or expansion.